CN1317034C - 核酸佐剂 - Google Patents

核酸佐剂 Download PDF

Info

Publication number
CN1317034C
CN1317034C CNB018195709A CN01819570A CN1317034C CN 1317034 C CN1317034 C CN 1317034C CN B018195709 A CNB018195709 A CN B018195709A CN 01819570 A CN01819570 A CN 01819570A CN 1317034 C CN1317034 C CN 1317034C
Authority
CN
China
Prior art keywords
composition
nucleic acid
subunit
dna
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018195709A
Other languages
English (en)
Chinese (zh)
Other versions
CN1537013A (zh
Inventor
约尔·R·海恩斯
约书亚·E·阿林顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Vaccines Inc
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Publication of CN1537013A publication Critical patent/CN1537013A/zh
Application granted granted Critical
Publication of CN1317034C publication Critical patent/CN1317034C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB018195709A 2000-11-27 2001-11-26 核酸佐剂 Expired - Fee Related CN1317034C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72431500A 2000-11-27 2000-11-27
US09/724,315 2000-11-27

Publications (2)

Publication Number Publication Date
CN1537013A CN1537013A (zh) 2004-10-13
CN1317034C true CN1317034C (zh) 2007-05-23

Family

ID=24909936

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018195709A Expired - Fee Related CN1317034C (zh) 2000-11-27 2001-11-26 核酸佐剂

Country Status (16)

Country Link
EP (1) EP1379273B1 (https=)
JP (1) JP4221289B2 (https=)
KR (1) KR20040045391A (https=)
CN (1) CN1317034C (https=)
AT (1) ATE442858T1 (https=)
AU (1) AU2001297988B2 (https=)
BR (1) BR0115646A (https=)
CA (1) CA2429708A1 (https=)
DE (1) DE60139959D1 (https=)
DK (1) DK1379273T3 (https=)
ES (1) ES2332261T3 (https=)
IL (2) IL156041A0 (https=)
MX (1) MXPA03004638A (https=)
NZ (1) NZ526175A (https=)
PT (1) PT1379273E (https=)
WO (1) WO2003004055A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035771A2 (en) 2003-10-10 2005-04-21 Powderject Vaccines, Inc. Nucleic acid constructs
AU2005212479B2 (en) 2004-02-11 2009-09-10 Msd Italia S.R.L. Carcinoembryonic antigen fusion proteins and uses thereof
GB0507997D0 (en) * 2005-02-01 2005-05-25 Powderject Vaccines Inc Nucleic acid constructs
US8389686B2 (en) 2008-05-07 2013-03-05 Osaka University Noncovalent collagen crosslinking agent
EP2616045B1 (en) 2010-09-15 2017-10-25 Randall J. Mrsny Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences
US11246915B2 (en) 2010-09-15 2022-02-15 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
CN103060253A (zh) * 2013-01-24 2013-04-24 麻丽丹 霍乱弧菌ctxAB基因的质粒克隆菌株以及制备方法和应用
PL3139965T3 (pl) 2014-05-07 2022-01-31 Applied Molecular Transport Inc. Cząsteczki fuzyjne pochodzące z toksyny cholix do doustnego dostarczania ładunku biologicznie czynnego
EP4082558B1 (en) 2018-03-08 2023-08-23 Applied Molecular Transport Inc. Toxin-derived delivery constructs for oral delivery
KR20210110294A (ko) 2018-11-07 2021-09-07 어플라이드 몰레큘라 트랜스포트 인크. 통과세포외배출용 전달 구조체 및 관련 방법
CN114599665A (zh) 2019-08-16 2022-06-07 应用分子转运公司 组合物、制剂及白细胞介素产生和纯化

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US6056960A (en) * 1995-06-07 2000-05-02 Kaslow; Harvey R. Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
GB9416663D0 (en) 1994-08-17 1994-10-12 Oxford Bioscience Limited Particle delivery
CA2199417C (en) 1994-10-24 2008-07-08 Brian John Bellhouse Particle delivery
GB9426379D0 (en) 1994-12-23 1995-03-01 Oxford Biosciences Ltd Particle delivery
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056960A (en) * 1995-06-07 2000-05-02 Kaslow; Harvey R. Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Transcutaneous immunization with bacterial ADP-ribosylatingexotoxins as antigens and adjuvants GLENN G M,INFECTION AND IMMUNITY,Vol.67 No.3 1999 *
Transcutaneous immunization with bacterialADP-ribosylating exotoxins,subunits,and unrelated adjuvants SCHARTON.KERSTEN T,INFECTION AND IMMUNITY,Vol.68 No.9 2000 *

Also Published As

Publication number Publication date
JP2004536107A (ja) 2004-12-02
EP1379273B1 (en) 2009-09-16
WO2003004055A2 (en) 2003-01-16
PT1379273E (pt) 2009-11-27
WO2003004055A3 (en) 2003-11-20
ATE442858T1 (de) 2009-10-15
DK1379273T3 (da) 2009-11-09
CN1537013A (zh) 2004-10-13
AU2001297988B2 (en) 2006-10-26
BR0115646A (pt) 2005-12-13
ES2332261T3 (es) 2010-02-01
JP4221289B2 (ja) 2009-02-12
NZ526175A (en) 2006-01-27
IL156041A (en) 2010-05-17
CA2429708A1 (en) 2003-01-16
EP1379273A2 (en) 2004-01-14
KR20040045391A (ko) 2004-06-01
IL156041A0 (en) 2003-12-23
DE60139959D1 (de) 2009-10-29
MXPA03004638A (es) 2004-04-20

Similar Documents

Publication Publication Date Title
AU2016202122B2 (en) Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof
CN1890375A (zh) 核酸构建体
CN1317034C (zh) 核酸佐剂
KR101891195B1 (ko) 공통 항원 구성체 및 이것으로부터 만들어진 백신 및 말라리아를 치료하기 위한 이것의 사용방법
CN1368885A (zh) 用于鉴定引起免疫反应的抗原的组合物和方法
CN113423434A (zh) 用于基因递送的重组腺相关病毒载体
KR102382942B1 (ko) B형 간염 바이러스 코어 단백질 및 표면 항원 단백질 및 이를 포함하는 백신
CN1177863C (zh) 用于治疗感染的减毒微生物
CN1515319A (zh) 细胞毒t淋巴细胞应答的诱导
CN1214083A (zh) Hiv多包膜蛋白疫苗的重组痘苗载体混合物
JP2004500047A (ja) キメラ免疫原性組成物およびこれらをコードする核酸
HK1040261A1 (zh) 负调节osteoprotegerin配体活性的方法
WO1996037626A1 (en) Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
CN114134165B (zh) 一种新型hpv治疗性核酸疫苗
KR20090083340A (ko) 장기 지속형 약물 제형
KR20250136930A (ko) 사람 파필로마바이러스 백신 및 이의 용도
KR20230087583A (ko) 항원을 mhc-ii 경로로 전달하고 숙주에서 cd4+ 및 cd8+ t-세포 반응을 유도하는 새로운 세대의 렌티바이러스 벡터
CN1889963A (zh) 方法
DK2844759T3 (en) Vaccination by recombinant yeast by eliciting a protective humoral immune response against defined antigens
AU2019231652B2 (en) Hepatitis B vaccines and uses of the same
JP2003516741A (ja) コドン最適化ＨＩＶ−１Ｎｅｆ及び修飾ＨＩＶ−１Ｎｅｆを発現するポリヌクレオチドワクチン
CN101048178A (zh) 作为疫苗的重组分枝杆菌和生物活性剂的组合
US20030162733A1 (en) Nucleic acid adjuvants
CN114514316A (zh) 慢性肉芽肿病的治疗
CN1701120A (zh) 用于基因表达的核酸构建体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070523

Termination date: 20111126